메뉴 건너뛰기




Volumn 43, Issue 3, 2005, Pages 219-220

Poisoning with insulin glargine [4]

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN; POTASSIUM;

EID: 18744415052     PISSN: 07313810     EISSN: None     Source Type: Journal    
DOI: 10.1081/CLT-200056408     Document Type: Letter
Times cited : (22)

References (4)
  • 1
    • 0041733061 scopus 로고    scopus 로고
    • Insulin glargine: An updated review of its use in the management of diabetes mellitus
    • Dunn CJ, Plosker GL, Keating GM, McKeage K, Scott LJ. Insulin glargine: an updated review of its use in the management of diabetes mellitus. Drugs 2003; 63:1743-1778.
    • (2003) Drugs , vol.63 , pp. 1743-1778
    • Dunn, C.J.1    Plosker, G.L.2    Keating, G.M.3    McKeage, K.4    Scott, L.J.5
  • 2
    • 0024459129 scopus 로고
    • Massive insulin overdose: Detailed studies of free insulin levels and glucose requirements
    • Samuels MH, Eckel EM. Massive insulin overdose: detailed studies of free insulin levels and glucose requirements. J Toxicol Clin Toxicol 1989; 27:157-168.
    • (1989) J Toxicol Clin Toxicol , vol.27 , pp. 157-168
    • Samuels, M.H.1    Eckel, E.M.2
  • 3
    • 0242721280 scopus 로고    scopus 로고
    • Comparison of the subcutaneous absorption of insulin glargine (Lantus) and NPH insulin in patients with Type 2 diabetes
    • Luzio SD, Beck P, Owens DR. Comparison of the subcutaneous absorption of insulin glargine (Lantus) and NPH insulin in patients with Type 2 diabetes. Horm Metab Res 2003; 35:434-438.
    • (2003) Horm Metab Res , vol.35 , pp. 434-438
    • Luzio, S.D.1    Beck, P.2    Owens, D.R.3
  • 4
    • 0034203532 scopus 로고    scopus 로고
    • Pharmacokinetics of 1251-labeled insulin glargine (HOE 901) in healthy men: Comparison with NPH insulin and the influence of different subcutaneous injection sites
    • Owens DR, Coates PA, Luzio SD, Tinbergen JP, Kurzhals R. Pharmacokinetics of 1251-labeled insulin glargine (HOE 901) in healthy men: comparison with NPH insulin and the influence of different subcutaneous injection sites. Diabetes Care 2000; 23:813-819.
    • (2000) Diabetes Care , vol.23 , pp. 813-819
    • Owens, D.R.1    Coates, P.A.2    Luzio, S.D.3    Tinbergen, J.P.4    Kurzhals, R.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.